Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • IP WRITING CHALLENGE
    Home
    >
    IP
    >
    Patents
    >
    Access to Medicines

    Category: Access to Medicines

    March 10, 2022in Access to Medicines, Blogs, IP, IP Reform, Patents0by Editor
    1702

    The Final Countdown? The Upcoming Changes to the Patented Medicines Regulations

    Jasmine Yu is an IPilogue Writer and a 1L JD Candidate at the University of Toronto.   After numerous delays over two years, amendments to the Patented Medicines Regulations, which governs Canada’s Patented…

    Read more
    February 17, 2022in Access to Medicines, Blogs, IP, Patents0by Editor
    1483

    How IP Waivers Can Help Manage the Omicron Strain

    Shannon Flynn is a Guest Writer and the Managing Editor of ReHack Magazine. Over two years have passed since the SARS-CoV-2 virus, better known today as COVID-19, made its first…

    Read more
    October 5, 2021in Access to Medicines, Blogs, IP, Patents, Technology0by Editor
    1215

    Reducing the Canadian carbon footprint through ESG Energy’s granting of exclusive patent rights

    Meena Alnajar is an IPilogue Writer, IP Innovation Clinic Fellow, and a 2L JD Candidate at Osgoode Hall Law School.   Leaves may be falling in time for autumn, but…

    Read more
    August 25, 2021in Access to Medicines, Blogs, Patents, Pharmaceutical Drugs, US0by Editor
    2269

    Insulin Biohackers: Shaking Up a Billion-Dollar Industry

    Natalie Bravo is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School.   Brief History of Insulin In 1921, Dr. Frederick Banting, Charles Best, and James…

    Read more
    May 12, 2021in Access to Medicines, Blogs, Development, IP Reform, Patents0by Editor
    1719

    Biden Support for Covid-19 Intellectual Property Waiver: A Step Below Progress?

    Ryan Erdman is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School.      In a truly monumental achievement in scientific innovation, there are now over a dozen authorized COVID-19…

    Read more
    August 16, 2017in Access to Medicines, Blogs, Commercialization, Development, Innovation, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
    1618

    Broken Promises: Utility Standards and Patent Applications in Canada

    The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was…

    Read more

    Posts navigation

    1 2 … 6
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736